The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sunvozertinib monotherapy versus platinum-based chemotherapy as first-line treatment for advanced NSCLC with EGFR exon20ins: Primary analysis of a multinational phase 3 randomized study (WU-KONG28).
 
John Heymach
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Abbvie; ALK Positive; ArriVent Biopharma; AstraZeneca; BioNtech; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Lilly (Inst); Mirati Therapeutics; ModeX Therapeutics; Novartis; Ottimo Pharma; Regeneron; Sanofi/Aventis; Spectrum Pharmaceuticals; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Mirati Therapeutics; Spectrum Pharmaceuticals; Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations; Patents pending regarding classification of EGFR mutations; Patents pending regarding subtyping of SCLC lung cancer.
 
Geoffrey Liu
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; emd serono; Jazz Pharmaceuticals; Merck; novartis; nuvation bio; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca; Pfizer; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim; roche (Inst); Takeda
 
Ligang Xing
No Relationships to Disclose
 
Laurent Greillier
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Novartis; Novocure; Pfizer; Regeneron; Roche; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Novartis; Novocure; Roche; Takeda
Travel, Accommodations, Expenses - Amgen; AstraZeneca; BMS; MSD; Pfizer; Roche
 
John Thomas
No Relationships to Disclose
 
Ozan Yazici
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Yun Fan
No Relationships to Disclose
 
Chengzhi Zhou
No Relationships to Disclose
 
Mengzhao Wang
No Relationships to Disclose
 
Regan Memmott
Consulting or Advisory Role - J&J Innovative Medicine; Orion
Travel, Accommodations, Expenses - J&J Innovative Medicine; Orion
 
Dariusz Kowalski
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Johnson & Johnson/Janssen; Medison; Merck; Merck Serono; MSD; Pfizer; Roche/Genentech; Sanofi/Aventis; Takeda
 
Catherine Shu
Consulting or Advisory Role - AstraZeneca; EMD Serono; Genentech/Roche; Janssen
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Elaine Shum
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb/Roche; Genentech; Gilead Sciences; Janssen; Nuvalent, Inc.; Regeneron
Research Funding - AstraZeneca (Inst); Delfi Diagnostics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Janssen
 
Elvire Pons Tostivint
No Relationships to Disclose
 
Federica Bertolini
No Relationships to Disclose
 
Gonzalo Fernandez Hinojal
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - MSD
 
Lorenzo Antonuzzo
Honoraria - Amgen; AstraZeneca; Novartis; Roche
Consulting or Advisory Role - Merck Serono; MSD Oncology
 
Yiman Wang
Employment - Dizal Pharma
 
Caicun Zhou
Leadership - IASLC BOD
Honoraria - Akeso Biopharma; Alice; Amoy Diagnostics; Anheart Therapeutics; Hengrui Therapeutics; Innovent Biologics; Lilly; Luye Pharma; Merck Sharpe and Dohme; MSD; QiLu Pharmaceutical; Sanofi; TopAlliance BioSciences Inc
Consulting or Advisory Role - Amoy Diagnostics; Hengrui Therapeutics; Innovent Biologics; QiLu Pharmaceutical; Top Alliance BioScience